Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
RANI Rani Therapeutics Holdings Inc
- Stocks
- Healthcare
- NASDAQ: RANI
Price (delayed)
$0.4817
Market cap
$27.69M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.05
Enterprise value
$53.64M
Highlights
The EPS has increased by 21% YoY
The debt has declined by 12% since the previous quarter
The net income has grown by 12% YoY but it has contracted by 7% from the previous quarter
The company's equity has shrunk by 85% YoY and by 36% QoQ
The quick ratio has dropped by 77% year-on-year and by 7% since the previous quarter
Key stats
What are the main financial stats of RANI
Market
Valuations
Earnings
Shares outstanding
57.48M
Market cap
$27.69M
Enterprise value
$53.64M
Price to earnings (P/E)
N/A
Price to book (P/B)
13.85
Price to sales (P/S)
13.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
52.18
Revenue
$1.03M
Gross profit
$1.03M
Operating income
-$53.31M
Net income
-$30.02M
EBIT
-$24.99M
EBITDA
-$22.15M
Free cash flow
-$35.76M
Per share
Balance sheet
Liquidity
EPS
-$1.05
EPS diluted
-$1.05
Free cash flow per share
-$1.26
Book value per share
$0.03
Revenue per share
$0.04
TBVPS
$1.29
Total assets
$36.63M
Total liabilities
$33.14M
Debt
$29.71M
Equity
$1.99M
Working capital
$9.85M
Debt to equity
14.91
Current ratio
1.5
Quick ratio
1.39
Net debt/EBITDA
-1.17
Margins
Efficiency
Dividend
EBITDA margin
-2,154.5%
Gross margin
100%
Net margin
-2,920%
Operating margin
-5,186.2%
Return on assets
-67.7%
Return on equity
-782.5%
Return on invested capital
-45%
Return on capital employed
-149.2%
Return on sales
-2,430.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RANI stock price
How has the Rani Therapeutics Holdings stock price performed over time
Intraday
-21.42%
1 week
-55.4%
1 month
-59.52%
1 year
-92.12%
YTD
-64.84%
QTD
-61.77%
Financial performance
How have Rani Therapeutics Holdings's revenue and profit performed over time
Revenue
$1.03M
Gross profit
$1.03M
Operating income
-$53.31M
Net income
-$30.02M
Gross margin
100%
Net margin
-2,920%
The operating income has grown by 19% YoY but it has contracted by 2.9% from the previous quarter
The net income has grown by 12% YoY but it has contracted by 7% from the previous quarter
Price vs fundamentals
How does RANI's price correlate with its fundamentals
Growth
What is Rani Therapeutics Holdings's growth rate over time
Valuation
What is Rani Therapeutics Holdings stock price valuation
P/E
N/A
P/B
13.85
P/S
13.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
52.18
The EPS has increased by 21% YoY
The company's equity has shrunk by 85% YoY and by 36% QoQ
RANI's P/B is 66% below its last 4 quarters average of 41.3
Efficiency
How efficient is Rani Therapeutics Holdings business performance
Rani Therapeutics Holdings's return on equity has shrunk by 82% QoQ
The ROA has plunged by 54% YoY and by 19% from the previous quarter
RANI's ROIC is down by 42% YoY and by 24% from the previous quarter
Dividends
What is RANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RANI.
Financial health
How did Rani Therapeutics Holdings financials performed over time
Rani Therapeutics Holdings's total assets is 11% more than its total liabilities
The quick ratio has dropped by 77% year-on-year and by 7% since the previous quarter
The current ratio has shrunk by 76% YoY and by 6% QoQ
The company's equity has shrunk by 85% YoY and by 36% QoQ
The company's debt to equity rose by 38% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.